Avalo Therapeutics Inc以225万美元购得Almatabio前股东期权

美股速递04-28

Avalo Therapeutics Inc（股票代码：AVTX）近日与生物技术公司Almatabio的前股东达成一项期权协议。根据协议条款，Avalo将支付225万美元，以获得特定资产或技术的优先认购权。

这笔交易体现了Avalo在拓展其治疗管线方面的战略布局。通过支付期权费用，公司得以在未来特定条件下行使收购权利，为潜在的技术整合或产品开发预留空间。

此次期权协议的金额虽不大，但反映出生物科技领域企业通过灵活的交易结构强化研发实力的趋势。市场关注Avalo是否会基于该期权进一步推进相关领域的业务部署。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1162862694?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-28 19:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162862694","market":"us","top_or_hot":-1,"title":"Avalo Therapeutics Inc以225万美元购得Almatabio前股东期权","media":"美股速递","content":"<p>Avalo Therapeutics Inc（股票代码：AVTX）近日与生物技术公司Almatabio的前股东达成一项期权协议。根据协议条款，Avalo将支付225万美元，以获得特定资产或技术的优先认购权。</p>\n<p>这笔交易体现了Avalo在拓展其治疗管线方面的战略布局。通过支付期权费用，公司得以在未来特定条件下行使收购权利，为潜在的技术整合或产品开发预留空间。</p>\n<p>此次期权协议的金额虽不大，但反映出生物科技领域企业通过灵活的交易结构强化研发实力的趋势。市场关注Avalo是否会基于该期权进一步推进相关领域的业务部署。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avalo Therapeutics Inc以225万美元购得Almatabio前股东期权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvalo Therapeutics Inc以225万美元购得Almatabio前股东期权\n</h2>\n\n<h4 class=\"meta\">\n\n2026-04-28 19:14 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Avalo Therapeutics Inc（股票代码：AVTX）近日与生物技术公司Almatabio的前股东达成一项期权协议。根据协议条款，Avalo将支付225万美元，以获得特定资产或技术的优先认购权。\n这笔交易体现了Avalo在拓展其治疗管线方面的战略布局。通过支付期权费用，公司得以在未来特定条件下行使收购权利，为潜在的技术整合或产品开发预留空间。\n此次期权协议的金额虽不大，但反映出生物科技...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVTX","symbol_name":"Avalo Therapeutics Inc","start_time":0,"source_url":"","article_id":"1162862694","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162862694","pubTimestamp":1777374859,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Avalo Therapeutics Inc（股票代码：AVTX）近日与生物技术公司Almatabio的前股东达成一项期权协议。根据协议条款，Avalo将支付225万美元，以获得特定资产或技术的优先认购权。\n这笔交易体现了Avalo在拓展其治疗管线方面的战略布局。通过支付期权费用，公司得以在未来特定条件下行使收购权利，为潜在的技术整合或产品开发预留空间。\n此次期权协议的金额虽不大，但反映出生物科技领域企业通过灵活的交易结构强化研发实力的趋势。市场关注Avalo是否会基于该期权进一步推进相关领域的业务部署。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AVTX":"Avalo Therapeutics Inc","BK4139":"生物科技"},"translate_title":"Avalo Therapeutics Inc Acquires Almatabio Former Shareholder Options for $2.25M","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVTX":1},"content_text":"Avalo Therapeutics Inc（股票代码：AVTX）近日与生物技术公司Almatabio的前股东达成一项期权协议。根据协议条款，Avalo将支付225万美元，以获得特定资产或技术的优先认购权。\n这笔交易体现了Avalo在拓展其治疗管线方面的战略布局。通过支付期权费用，公司得以在未来特定条件下行使收购权利，为潜在的技术整合或产品开发预留空间。\n此次期权协议的金额虽不大，但反映出生物科技领域企业通过灵活的交易结构强化研发实力的趋势。市场关注Avalo是否会基于该期权进一步推进相关领域的业务部署。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162862694","isCrawlerRequest":true}